A National Pulmonary Hypertension Service for England & Wales: An orphan disease is adopted?

Thorax

Volumn 57, Issue 6, 2002, Pages 471-472

  Evans, T W ^a   Gatzoulis, M A ^a   Gibbs, J S R ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANOREXIGENIC AGENT; BOSENTAN; CALCIUM CHANNEL BLOCKING AGENT; COCAINE; ENDOTHELIN 1; ENDOTHELIN RECEPTOR ANTAGONIST; METHAMPHETAMINE; MONOCROTALINE; NITRIC OXIDE; PHOSPHODIESTERASE INHIBITOR; PROSTACYCLIN DERIVATIVE; RAPESEED OIL; SILDENAFIL; SOLVENT; TRANSFORMING GROWTH FACTOR BETA; TRYPTOPHAN;

CHROMOSOMAL LOCALIZATION; CHROMOSOME 2Q; CLINICAL TRIAL; ENVIRONMENTAL FACTOR; FEMALE; HUMAN; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SCREENING TEST; SHORT SURVEY; SURVIVAL RATE; UNITED KINGDOM; VASODILATATION;

ENGLAND; HUMANS; HYPERTENSION, PULMONARY; NATIONAL HEALTH PROGRAMS; PROGNOSIS; WALES;

EID: 0036285910     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thorax.57.6.471     Document Type: Short Survey

References (13)

1. Primary pulmonary hypertension
2. Anorexigens and pulmonary hypertension in the United States: Results from the surveillance of North American pulmonary hypertension
3. Genetics of primary pulmonary hypertension
4. Heterozygous germ-line mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension
5. Endogenously released endothelin-1 from human pulmonary artery smooth muscle promotes cellular proliferation: Relevance to pathogenesis of pulmonary hypertension and vascular remodelling
6. Endothelin-1: A mediator of pulmonary hypertension?
7. Recommendations on the management of pulmonary hypertension in clinical practice
8. Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension
9. The prostocyclin mimetic cicoprost inhibits endogenous endothlein-1 release from human pulmonary artery smooth muscle cells
10. Long-term treatment of primary pulmonary hypertension with aerosolized iloprost, a prostacyclin analogue
11. Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: A randomised placebo-controlled study
12. Sildenafil in primary pulmonary hypertension
13. Effect of inhaled iloprost plus oral sildenafil in patients with primary pulmonary hypertension